Lyell Immunopharma

Press Releases

Lyell Immunopharma Goes All-In on AWS as its Cloud Provider

SEATTLE–(BUSINESS WIRE)–May 19, 2020– Today, Amazon Web Services, Inc. (AWS), an Amazon.com company (NASDAQ: AMZN), announced that Lyell Immunopharma is going all-in on AWS—running its cloud infrastructure on AWS—and has selected AWS as its standard for machine learning (ML) workloads. Lyell leverages AWS’s highly performant and scalable infrastructure to run its secure data and analytics platform as well as support its high-performance computing workloads…